Lotus Pharmaceutical Co. Ltd.

Lotus Pharmaceutical is set to further expand its oncology and women’s health products while bolting on a fresh ophthalmic and respiratory portfolio and expanding its presence in Southeast Asia after

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Citeline's Biomedtracker. Lotus Licenses Corium’s Alzh

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Antibiotics Firm Agrees To Go Private F

Glenmark Pharmaceuticals Limited has entered into an exclusive licensing agreement with Lotus Pharmaceutical Co. Ltd. to commercialize its Ryaltris (olopatadine hydrochloride/mometasone furoate) 66